Drug Profile
Cetefloxacin
Alternative Names: E 4868Latest Information Update: 07 Oct 1998
Price :
$50
*
At a glance
- Originator Esteve
- Class Antibacterials; Fluoroquinolones; Small molecules
- Mechanism of Action DNA gyrase inhibitors; DNA topoisomerase IV inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 07 Oct 1998 Suspended-I for Bacterial infections in European Union (PO)
- 07 Oct 1998 Suspended-Preclinical for Bacterial infections in USA (PO)
- 15 May 1997 Phase-I clinical trials for Bacterial infections in European Union (PO)